Dr. Sheila Oren
CEO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
Pharma Two B
Former names:
Innovative Combinations of Previously Approved Drugs
Stealth Mode
Jul 2025 ceased to operate
Pharma Two B
Pharma Two B Overview
Pharma Two B is a clinical-stage pharmaceutical company that is developing differentiated and value-added products based on previously approved drugs. The company's aim is to improve efficacy, safety, and delivery profiles with the goal of increasing clinical value and decreasing the timeline to regulatory approval.
Pharma Two B's lead product candidate, P2B001, is being investigated as a treatment for early-stage Parkinson's disease. P2B001 has shown remarkable results in phase-2 clinical trials (149 patients) and is currently undergoing phase-3 clinical trials.
Pharma Two B's lead product candidate, P2B001, is being investigated as a treatment for early-stage Parkinson's disease. P2B001 has shown remarkable results in phase-2 clinical trials (149 patients) and is currently undergoing phase-3 clinical trials.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Pharma Two B Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Mar 11, 2025
www.themarker.com
כישלון בייצור התרופה הפיל את פארמה 2 בי: ביקשה צו פתיחת הליכים
undefined
Sep 3, 2024
www.globenewswire.com
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger
#Acquired-by #Public Trading
Jul 21, 2024
www.fiercebiotech.com
In struggling Hepion, Israeli biotech spies path to go public before seeking FDA approval
#Acquired-by #Investment
Apr 5, 2022
www.globenewswire.com
Pharma Two B Presents Late-Breaker Abstract on Positive Efficacy and Safety Data of P2B001 from Phase 3 Trial at American Academy of Neurology (AAN) Annual Meeting
#Customers
Dec 15, 2021
www.prnewswire.com
Pharma Two B Announces Positive Topline Results from its Pivotal Phase III Study of P2B001 in Early Parkinson's Disease
#Investment
Companies you might be interested in
Driven by Finder AI
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
DO
DL
IZ
Contact Team
Affiliated Organizations
(null)Web & social links
Locations
Israel
Prof. Haim Pekeris St 3, Rehovot, Israel
Offices Abroad
Photos & videos
(0)No Data, yet.
Sorry, no content found under this section.
Pharma Two B Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)Pharma Two B Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Private Equity Funding
C Round
$30M
Feb 2017
6
Investors
$30M
B Round
$8M
Oct 2012
3
Investors
$8M
A Round
$3.11M
Nov 2007
0
Investors
$3.11M
Non-Equity Funding
Mergers and Acquisitions
Pharma Two B Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
Closing Event
Jul 2025
C Round
$30M
Feb 2017
6
Investors
$30M
B Round
$8M
Oct 2012
3
Investors
$8M
A Round
$3.11M
Nov 2007
0
Investors
$3.11M
Pharma Two B News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Mar 11, 2025
www.themarker.com
כישלון בייצור התרופה הפיל את פארמה 2 בי: ביקשה צו פתיחת הליכים
undefined
Sep 3, 2024
www.globenewswire.com
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form F-4 Related to Proposed Merger
#Acquired-by #Public Trading
Jul 21, 2024
www.fiercebiotech.com
In struggling Hepion, Israeli biotech spies path to go public before seeking FDA approval
#Acquired-by #Investment
Apr 5, 2022
www.globenewswire.com
Pharma Two B Presents Late-Breaker Abstract on Positive Efficacy and Safety Data of P2B001 from Phase 3 Trial at American Academy of Neurology (AAN) Annual Meeting
#Customers
Dec 15, 2021
www.prnewswire.com
Pharma Two B Announces Positive Topline Results from its Pivotal Phase III Study of P2B001 in Early Parkinson's Disease
#Investment
Related Content
Pharma Two B Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
Pharma Two B Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,